| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
2,498 |
2,377 |
$96K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,626 |
2,544 |
$89K |
| 36902 |
|
1,168 |
1,052 |
$74K |
| 99223 |
Prolong inpt eval add15 m |
263 |
238 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
448 |
383 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
149 |
129 |
$6K |
| 99233 |
Prolong inpt eval add15 m |
196 |
90 |
$4K |
| 90961 |
|
124 |
114 |
$3K |
| 99152 |
|
742 |
672 |
$3K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
162 |
97 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
20 |
17 |
$590.54 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
47 |
28 |
$347.82 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
49 |
45 |
$73.24 |
| 36907 |
|
15 |
13 |
$38.50 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
83 |
72 |
$11.38 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
97 |
86 |
$3.68 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
946 |
837 |
$0.00 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
1,790 |
1,656 |
$0.00 |